Overview

Update
Total Equity Funding
$45.28M in 9 Rounds from 5 Investors
Most Recent Funding
$14M Venture on April 3, 2012
Headquarters:
Lebanon, NH
Description:
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.
Founders:
, ,
Categories:
Therapeutics, Collaboration, Biotechnology
Website:
http://www.adimab.com

Company Details

Update

Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

Funding Rounds (9) - $45.28M

Update
DateAmount / RoundValuationLead InvestorInvestors
Apr, 2012$14M / Venture3
Apr, 2012undisclosed amount / Series F0
Dec, 2010$4M / Venture0
Jan, 2010$8.2M / Series D5
Nov, 2008$4M / Series C4
Apr, 2008$3.18M / Series B0
Sep, 2007$5.9M / Series A2
Jul, 2007$6M / Series A2
Jul, 2007$2.38k / Seed0

Current Team (9)

Update

Offices/Locations (1)

Update
  • Office

    16 Cavendish Court

    Lebanon, NH 03766

    USA

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos